Cargando…

Expression of APOBEC3G/3F and G-to-A Hypermutation Levels in HIV-1-Infected Children with Different Profiles of Disease Progression

OBJECTIVE: Increasing evidence has accumulated showing the role of APOBEC3G (A3G) and 3F (A3F) in the control of HIV-1 replication and disease progression in humans. However, very few studies have been conducted in HIV-infected children. Here, we analyzed the levels of A3G and A3F expression and ind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amoêdo, Nívea D., Afonso, Adriana O., Cunha, Sílvia M., Oliveira, Ricardo H., Machado, Elizabeth S., Soares, Marcelo A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163681/ https://www.ncbi.nlm.nih.gov/pubmed/21897871 http://dx.doi.org/10.1371/journal.pone.0024118

Ejemplares similares

APOBEC3G-Mediated G-to-A Hypermutation of the HIV-1 Genome: The Missing Link in Antiviral Molecular Mechanisms
por: Okada, Ayaka, et al.
Publicado: (2016)

Minimal Contribution of APOBEC3-Induced G-to-A Hypermutation to HIV-1 Recombination and Genetic Variation
por: Delviks-Frankenberry, Krista A., et al.
Publicado: (2016)

HIV-1 Vif inhibits G to A hypermutations catalyzed by virus-encapsidated APOBEC3G to maintain HIV-1 infectivity
por: Wang, Yudi, et al.
Publicado: (2014)

APOBEC3G and APOBEC3F rarely co-mutate the same HIV genome
por: Ebrahimi, Diako, et al.
Publicado: (2012)

The Roles of APOBEC3G Complexes in the Incorporation of APOBEC3G into HIV-1
por: Ma, Jing, et al.
Publicado: (2013)

APOBEC3G and APOBEC3F Require an Endogenous Cofactor to Block HIV-1 Replication
por: Han, Yanxing, et al.
Publicado: (2008)

Human APOBEC3G-mediated hypermutation is associated with antiretroviral therapy failure in HIV-1 subtype C-infected individuals
por: Neogi, Ujjwal, et al.
Publicado: (2013)

Role of co-expressed APOBEC3F and APOBEC3G in inducing HIV-1 drug resistance
por: Mohammadzadeh, Nazanin, et al.
Publicado: (2019)

HIV-1 adaptation studies reveal a novel Env-mediated homeostasis mechanism for evading lethal hypermutation by APOBEC3G
por: Ikeda, Terumasa, et al.
Publicado: (2018)

APOBEC3G-Induced Hypermutation of Human Immunodeficiency Virus Type-1 Is Typically a Discrete “All or Nothing” Phenomenon
por: Armitage, Andrew E., et al.
Publicado: (2012)

Encapsidation of APOBEC3G into HIV-1 virions involves lipid raft association and does not correlate with APOBEC3G oligomerization
por: Khan, Mohammad A, et al.
Publicado: (2009)

An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers
por: Chan, Kin, et al.
Publicado: (2015)

APOBEC3G levels predict rates of progression to AIDS
por: Jin, Xia, et al.
Publicado: (2007)

The cellular source for APOBEC3G's incorporation into HIV-1
por: Ma, Jing, et al.
Publicado: (2011)

Evasion of adaptive immunity by HIV through the action of host APOBEC3G/F enzymes
por: Grant, Michael, et al.
Publicado: (2017)

Keratinocyte differentiation induces APOBEC3A, 3B, and mitochondrial DNA hypermutation
por: Wakae, Kousho, et al.
Publicado: (2018)

APOBEC3G-UBA2 fusion as a potential strategy for stable expression of APOBEC3G and inhibition of HIV-1 replication
por: Li, Lin, et al.
Publicado: (2008)

Intracellular interactions between APOBEC3G, RNA, and HIV-1 Gag: APOBEC3G multimerization is dependent on its association with RNA
por: Friew, Yeshitila N, et al.
Publicado: (2009)

Human Retroviral Host Restriction Factors APOBEC3G and APOBEC3F Localize to mRNA Processing Bodies
por: Wichroski, Michael J, et al.
Publicado: (2006)

Different Mutagenic Potential of HIV-1 Restriction Factors APOBEC3G and APOBEC3F Is Determined by Distinct Single-Stranded DNA Scanning Mechanisms
por: Ara, Anjuman, et al.
Publicado: (2014)

APOBEC3G encapsidation into HIV-1 virions: which RNA is it?
por: Strebel, Klaus, et al.
Publicado: (2008)

APOBEC3G Inhibits Elongation of HIV-1 Reverse Transcripts
por: Bishop, Kate N., et al.
Publicado: (2008)

Retraction: the cellular source for APOBEC3G's incorporation into HIV-1
por: Ma, Jing, et al.
Publicado: (2011)

APOBEC3G expression and HIV-1 infection in Burkina Faso
por: Compaore, Tegwinde Rebeca, et al.
Publicado: (2018)

EBV‐LMP1 induces APOBEC3s and mitochondrial DNA hypermutation in nasopharyngeal cancer
por: Wakae, Kousho, et al.
Publicado: (2020)

DNA mismatch repair promotes APOBEC3-mediated diffuse hypermutation in human cancers
por: Mas-Ponte, David, et al.
Publicado: (2020)

APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection
por: Pion, Marjorie, et al.
Publicado: (2006)

Model Structure of Human APOBEC3G
por: Zhang, Kun-Lin, et al.
Publicado: (2007)

Uracil DNA Glycosylase Counteracts APOBEC3G-Induced Hypermutation of Hepatitis B Viral Genomes: Excision Repair of Covalently Closed Circular DNA
por: Kitamura, Kouichi, et al.
Publicado: (2013)

Prognostic value, immune signature and molecular mechanisms of the APOBEC family members APOBEC1, APOBEC3A, APOBEC3G and APOBEC3H in pancreatic adenocarcinoma
por: Duan, Yunjie, et al.
Publicado: (2022)

Different Modes of Retrovirus Restriction by Human APOBEC3A and APOBEC3G In Vivo
por: Stavrou, Spyridon, et al.
Publicado: (2014)

Aromatic disulfides as potential inhibitors against interaction between deaminase APOBEC3G and HIV infectivity factor: Inhibitors of interaction between APOBEC3G and Vif
por: Yan, Xiaoxuan, et al.
Publicado: (2022)

Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G
por: Iwatani, Yasumasa, et al.
Publicado: (2007)

HIV-1 Vif and APOBEC3G: Multiple roads to one goal
por: Goncalves, Joao, et al.
Publicado: (2004)

RNA-Dependent Oligomerization of APOBEC3G Is Required for Restriction of HIV-1
por: Huthoff, Hendrik, et al.
Publicado: (2009)

Degradation-Independent Inhibition of APOBEC3G by the HIV-1 Vif Protein
por: Stupfler, Benjamin, et al.
Publicado: (2021)

The structural basis for HIV-1 Vif antagonism of human APOBEC3G
por: Li, Yen-Li, et al.
Publicado: (2023)

Natural Variation in Vif: Differential Impact on APOBEC3G/3F and a Potential Role in HIV-1 Diversification
por: Simon, Viviana, et al.
Publicado: (2005)

Efficient deamination of 5-methylcytosines in DNA by human APOBEC3A, but not by AID or APOBEC3G
por: Wijesinghe, Priyanga, et al.
Publicado: (2012)

Likely Role of APOBEC3G-Mediated G-to-A Mutations in HIV-1 Evolution and Drug Resistance
por: Jern, Patric, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_4m4apn5gndllu6sfp0vrauukhc